AB
Healthcare & Life Sciences
Amberstone Biosciences
United Statesamberstonebio.com
Amberstone Biosciences is a Healthcare & Life Sciences startup based in the United States, most recent round Series A, 1 tracked investor.
Activeseries-a
series-a
Stage
1
Investors
About Amberstone Biosciences
Based in the United States, Amberstone Biosciences is a startup. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Amberstone Biosciences develops tumor microenvironment activated immunotherapeutics using its proprietary T-MATE™ technology to precisely trigger immune responses in tumors while minimizing harm to healthy tissues.
Explore Amberstone Biosciences's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.